Eric Topol

I mean, so for me, so into the new era of prevention that's been potentiated with these markers that you're adding a whole different level of sophistication of marker, I would say.

And we don't have very good systemic blood markers now.

We use high sensitivity CRP, maybe IL-6, but this is a whole different look being able to do this and

continuous in real time.

Now, other ways that this could be used are, you know, for trying to prevent Alzheimer's disease, autoimmune diseases.

One of the ones that you posited was heart failure by, for example, continuous measurement of the BNP peptides, the

that tell us about the impending heart failure.

You may want to comment about this whole idea of using a sensor for protein monitoring for precision medicine.

You know, absolutely.

There's unparalleled ways that this can go forward in both, as you say, research, but also in the management of and prevention of diseases.

I mean, the autoimmune disease category is way up there in the list.

Now, how do you move forward?

You've got this ingenious invention.

You've got a proof of it in the animal model.

How do we accelerate this so that it becomes something that we could use in the clinic?

Yeah, I mean, I've over the years tried to anticipate where things are going, and I haven't been as excited about

new technology as this one, Shaina.

Now, I want to sign up as patient zero when you're ready, okay?

You got it.

I want to know my inflammation status in real time.